Radiomics study for predicting the expression of PD-L1 in non -small cell lung cancer based on CT images and clinicopathologic features

被引：4
|
作者：
Sun, Zongqiong [1 ,2 ]
Hu, Shudong [2 ]
Ge, Yuxi [2 ]
Wang, Jun [3 ]
Duan, Shaofeng [4 ]
Song, Jiayang [4 ]
Hu, Chunhong [1 ]
Li, Yonggang [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou 215006, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
[3] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Sch Commun & Informat Engn, Shanghai, Peoples R China
[4] Gen Elect GE Healthcare China, Shanghai, Peoples R China
来源：
JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY | 2020年 / 28卷 / 03期
基金：
中国国家自然科学基金;
关键词：
IMMUNOTHERAPY; BIOMARKERS; CHALLENGES; STATISTICS; RISK;
D O I：
暂无
中图分类号：
TH7 [仪器、仪表];
学科分类号：
0804 ; 080401 ; 081102 ;
摘要：
引用
收藏
页码：449 / 459
页数：11
相关论文
共 50 条
  • [11] Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas
    Yoon, Jiyoung
    Suh, Young Joo
    Han, Kyunghwa
    Cho, Hyoun
    Lee, Hye-Jeong
    Hur, Jin
    Choi, Byoung Wook
    THORACIC CANCER, 2020, 11 (04) : 993 - 1004
  • [12] Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
    Adam, J.
    Le Stang, N.
    Rouquette, I.
    Cazes, A.
    Badoual, C.
    Pinot-Roussel, H.
    Tixier, L.
    Danel, C.
    Damiola, F.
    Damotte, D.
    Penault-Llorca, F.
    Lantuejoul, S.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 953 - 958
  • [13] Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer
    Lafuente-Sanchis, Aranzazu
    Zuniga, Angel
    Estors, Miriam
    Martinez-Hernandez, Nestor J.
    Cremades, Antonio
    Cuenca, Maria
    Galbis, Jose M.
    CLINICAL LUNG CANCER, 2017, 18 (02) : E109 - E116
  • [14] PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
    Larsen, Trine Vilsboll
    Hussmann, Dianna
    Niesen, Anders Lade
    CANCER COMMUNICATIONS, 2019, 39
  • [15] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [16] Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer
    Lupo, A.
    Alifano, M.
    Wislez, M.
    Boulle, G.
    Velut, Y.
    Biton, J.
    Cremer, I.
    Goldwasser, F.
    Leroy, K.
    Damotte, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (05) : 339 - 350
  • [17] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
    Munari, Enrico
    Zamboni, Giuseppe
    Marconi, Marcella
    Sommaggio, Marco
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Moretta, Francesca
    Mingari, Maria Cristina
    Salgarello, Matteo
    Terzi, Alberto
    Picece, Vincenzo
    Pomari, Carlo
    Lunardi, Gianluigi
    Cavazza, Alberto
    Rossi, Giulio
    Moretta, Lorenzo
    Bogina, Giuseppe
    ONCOTARGET, 2017, 8 (52): : 90123 - 90131
  • [18] Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by 18F-FDG PET/CT Radiomics and Clinicopathological Characteristics
    Li, Jihui
    Ge, Shushan
    Sang, Shibiao
    Hu, Chunhong
    Deng, Shengming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [19] A Study on the Clinical Significance of Blood Exosomal PD-L1 in Non-Small Cell Lung Cancer Patients and its Correlation with PD-L1 in Tumor Tissues
    Cheng, Yonghong
    Chang, Feiyun
    Gong, Yanmei
    Lu, Ping
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (11) : 788 - 793
  • [20] Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Nonesmall-cell Lung Cancer
    Jiang, Tao
    Liu, Hongcheng
    Qiao, Meng
    Li, Xuefei
    Zhao, Chao
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    CLINICAL LUNG CANCER, 2018, 19 (02) : E177 - E184
12345